Trident Lifeline Limited's Board of Directors, at its meeting held on 7th May, 2026, approved the audited standalone and consolidated financial results for the half year and year ended 31st March, 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The statutory audit was conducted by M/s A Bafna & Associates, Chartered Accountants (Firm Registration No. 121901W), Surat, who issued an unmodified opinion on both the standalone and consolidated financial results. The financial statements have been prepared in accordance with Indian GAAP, complying with Accounting Standards specified under Section 133 of the Companies Act, 2013.

Standalone Financial Performance

The company delivered a strong standalone performance for FY 2025-26, with net sales/income from operations rising to INR 10,189.95 lacs from INR 6,779.91 lacs in FY 2024-25. Total income, including other income of INR 417.09 lacs, stood at INR 10,607.05 lacs compared to INR 7,094.00 lacs in the previous year. Net profit for the year grew to INR 1,809.27 lacs from INR 1,305.13 lacs in FY 2024-25.

The following table summarises the key standalone profit and loss metrics:

For the second half year ended 31st March, 2026, standalone net profit stood at INR 967.56 lacs, compared to INR 664.71 lacs in the corresponding half year ended 31st March, 2025. Paid-up equity share capital as at 31st March, 2026 was INR 1,193.30 lacs (face value INR 10/- each).

Standalone Balance Sheet Highlights

The standalone balance sheet as at 31st March, 2026 reflects significant growth in the company's asset base. Total assets expanded to INR 15,919.06 lacs from INR 9,779.20 lacs as at 31st March, 2025, driven by increases across both non-current and current assets.

Standalone Cash Flow

On a standalone basis, net cash flow from operating activities for the year ended 31st March, 2026 stood at INR 793.22 lacs, compared to INR 197.07 lacs in the previous year. Net cash used in investing activities was INR (2,007.36) lacs, reflecting increased capital expenditure including purchase of fixed assets worth INR 1,511.78 lacs. Net cash from financing activities amounted to INR 1,409.76 lacs, supported by changes in share capital, securities premium, and share application money pending allotment. The closing balance of cash and cash equivalents stood at INR 406.64 lacs, up from INR 211.02 lacs at the start of the year.

Consolidated Financial Performance

On a consolidated basis, which includes Trident Lifeline Limited and its subsidiaries — TNS Pharma Private Limited, TLL Parenterals Limited, TLL Wellness Limited (formerly TLL Herbal Limited), TLL Elements Private Limited, and Trident Mediquip Limited — the group reported total income of INR 13,829.28 lacs for FY 2025-26, compared to INR 9,519.58 lacs in FY 2024-25. Net profit after minority interest for the year stood at INR 1,904.14 lacs, up from INR 1,174.79 lacs in the previous year.

Consolidated total assets grew to INR 23,682.90 lacs as at 31st March, 2026 from INR 15,600.50 lacs as at 31st March, 2025. Cash and cash equivalents on a consolidated basis stood at INR 422.22 lacs at year-end, compared to INR 246.05 lacs at the close of the previous year.

Consolidated Cash Flow

On a consolidated basis, net cash flow from operating activities for the year ended 31st March, 2026 was INR 469.07 lacs, compared to INR (398.50) lacs in the previous year. Net cash used in investing activities stood at INR (3,661.08) lacs, driven primarily by purchase of fixed assets worth INR 3,647.24 lacs. Net cash from financing activities amounted to INR 3,368.19 lacs, supported by changes in unsecured loans, securities premium, and share application money. The closing consolidated cash balance was INR 422.22 lacs, up from INR 246.05 lacs at the opening of the year.

Internal Auditor Appointment

In addition to approving the financial results, the Board of Directors approved the appointment of DAC & Co., Chartered Accountants (FRN: 137035W, PR: 014160), as Internal Auditor of the company for the Financial Year 2026-27. DAC & Co. is a Chartered Accountancy firm based in Surat, engaged in assignments including internal audit, forensic audit, concurrent audit, stock audit, and indirect taxes. Mr. Prateek Choudhary is a key partner at the firm, a fellow member of ICAI, and holds a degree in Bachelor of Commerce. The appointment is effective 7th May, 2026.

Investor Complaints and Compliance

The company reported nil investor complaints pending at the beginning of the year ended 31st March, 2026, nil complaints received during the period, and nil complaints pending at the end of the period. The Board meeting commenced at 05:00 PM and concluded at 06:15 PM on 7th May, 2026. The company is listed on the SME Platform of BSE and has been exempted from the applicability of IND-AS as per the proviso to Rule 4 of Companies (Indian Accounting Standards) Rules, 2015.

Trident Lifeline Limited has announced a board meeting scheduled for Tuesday, May 5, 2026, to review and approve crucial financial results for the fiscal year 2026. The company has formally notified BSE Limited about this important corporate development in accordance with regulatory requirements.

Board Meeting Agenda

The board meeting will address several key items as outlined in the company's official communication:

Regulatory Compliance

The meeting notification has been issued pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory framework mandates listed companies to provide advance notice of board meetings where financial results will be considered.

Trading Window Restrictions

In compliance with insider trading prevention measures, Trident Lifeline Limited has implemented specific trading restrictions:

• Closure Date: Trading window closed from April 1, 2026
• Reopening: 48 hours after results are made public on May 5, 2026
• Regulatory Basis: SEBI (Prohibition of Insider Trading) Regulations, 2015
• Internal Framework: Company's Code of Conduct

The trading window closure was communicated through the company's letter dated March 31, 2026, ensuring all stakeholders were adequately informed about the restrictions.

Company Information

Traident Lifeline Limited, formerly known as Trident Lifeline Private Limited, operates under CIN L51909GJ2014PLC078227. The company is listed on BSE with Stock ID TLL and maintains its registered office in Surat, Gujarat. The notification was signed by Company Secretary and Compliance Officer Nikita Sharma on April 29, 2026.